Login / Signup

Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.

Donald C MooreAmy C SoniBei HuElton T SmithJonathan LevineTamara K MoyoRyan JacobsNilanjan GhoshSteven I Park
Published in: British journal of haematology (2021)
Keyphrases
  • diffuse large b cell lymphoma
  • chronic lymphocytic leukemia
  • epstein barr virus
  • multiple myeloma
  • newly diagnosed
  • stem cell transplantation
  • acute lymphoblastic leukemia
  • high dose